136 related articles for article (PubMed ID: 31941803)
1. Bidirectional Relationship Between Primary Sjögren Syndrome and Non-Hodgkin Lymphoma: A Nationwide Taiwanese Population-based Study.
Wang LH; Wang WM; Lin CY; Lin SH; Shieh CC
J Rheumatol; 2020 Sep; 47(9):1374-1378. PubMed ID: 31941803
[TBL] [Abstract][Full Text] [Related]
2. Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: a nationwide population-based study.
Wang LH; Wang WM; Lin SH; Shieh CC
Rheumatology (Oxford); 2019 Jul; 58(7):1245-1249. PubMed ID: 30726952
[TBL] [Abstract][Full Text] [Related]
3. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
4. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan.
Weng MY; Huang YT; Liu MF; Lu TH
Ann Rheum Dis; 2012 Apr; 71(4):524-7. PubMed ID: 22072014
[TBL] [Abstract][Full Text] [Related]
6. The risk of cancer in patients with primary Sjögren syndrome: a single-center study from Turkey.
Aslan B; Öğüt TS; Erbasan F; Dilbil M; Çelik E; Terzioğlu ME; Yazısız V
Turk J Med Sci; 2022 Jun; 52(3):587-595. PubMed ID: 36326315
[TBL] [Abstract][Full Text] [Related]
7. The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjögren's syndrome: a single-centre, retrospective cohort study.
Mayer M; Martinic M; Reihl-Crnogaj M; Anic B
Rheumatol Int; 2023 Nov; 43(11):2031-2036. PubMed ID: 37491526
[TBL] [Abstract][Full Text] [Related]
8. The risk of cancer in patients with primary Sjögren syndrome; A single-center study from Turkey.
Aslan B; Öğüt TS; Erbasan F; Dilbil M; Çelik E; Terzioğlu ME; Yazisiz V
Turk J Med Sci; 2021 Nov; ():. PubMed ID: 34800937
[TBL] [Abstract][Full Text] [Related]
9. Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjögren's syndrome measured using the Korean Health Insurance Claims Database.
Ahn JK; Hwang J; Seo GH
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):40-46. PubMed ID: 31969226
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study.
Fallah M; Liu X; Ji J; Försti A; Sundquist K; Hemminki K
Ann Oncol; 2014 Oct; 25(10):2025-2030. PubMed ID: 25081899
[TBL] [Abstract][Full Text] [Related]
11. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
12. The association between primary Sjogren's syndrome and non-Hodgkin's lymphoma: a systematic review and meta-analysis of cohort studies.
Ansari N; Salesi M
Clin Rheumatol; 2024 May; ():. PubMed ID: 38722505
[TBL] [Abstract][Full Text] [Related]
13. Risk of malignancy in Korean patients with primary Sjögren's syndrome.
Kang J; Kim H; Kim J; Choi S; Jung SY; Jang EJ; Cho SK; Sung YK
Int J Rheum Dis; 2020 Aug; 23(9):1240-1247. PubMed ID: 32841507
[TBL] [Abstract][Full Text] [Related]
14. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
15. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
[TBL] [Abstract][Full Text] [Related]
16. Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.
Chattopadhyay S; Sud A; Zheng G; Yu H; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
Int J Cancer; 2018 Nov; 143(10):2449-2457. PubMed ID: 30238973
[TBL] [Abstract][Full Text] [Related]
17. Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study.
Cho SF; Yang YH; Liu YC; Hsiao HH; Huang CT; Wu CH; Tsai YF; Wang HC; Liu TC
PLoS One; 2015; 10(10):e0139289. PubMed ID: 26425850
[TBL] [Abstract][Full Text] [Related]
18. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis.
Liang Y; Yang Z; Qin B; Zhong R
Ann Rheum Dis; 2014 Jun; 73(6):1151-6. PubMed ID: 23687261
[TBL] [Abstract][Full Text] [Related]
19. Incidence of cancer in a cohort of patients with primary Sjögren syndrome in Argentina.
Brom M; Moyano S; Gandino IJ; Scolnik M; Soriano ER
Rheumatol Int; 2019 Oct; 39(10):1697-1702. PubMed ID: 31471716
[TBL] [Abstract][Full Text] [Related]
20. Risk of Overall and Site-specific Cancers in Behçet Disease: A Nationwide Population-based Study in Taiwan.
Wang LH; Wang WM; Hsu SM; Lin SH; Shieh CC
J Rheumatol; 2015 May; 42(5):879-84. PubMed ID: 25834207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
